Company news
Easton Pharmaceuticals Inc (OTC:EAPH) news
Easton Pharmaceuticals Inc news releases on 6ix. Latest, May 2, 2017: Easton Pharmaceuticals Announces Signing LOI For The Acquisition Of Revenue Producing…
Press releases — page 2
Easton Pharmaceuticals Announces Signing LOI For The Acquisition Of Revenue Producing, Israel Based Therapeutics Company, Herbs Of Kedem
May 2, 2017
Easton Pharmaceuticals Announces Signing NDA and Starts Negotiations For Acquisition
April 24, 2017
Easton Pharmaceuticals Announces Signing Of Purchase Agreement Completing The Acquisition Of Revenue Producing Vaporizer and e-Liquids Manufacturer iBliss, Inc.
April 20, 2017
Easton Pharmaceuticals Announces Finalization Of Agreement For The Acquisition Of Major Vaporizer and e-Liquids Manufacturer iBliss Inc; Annual Sales Projected To Once Again Reach $15,000,000 With Healthy Profit Margins in Excess of 40%
April 11, 2017
Easton Pharmaceuticals Announces Advancing $300,000 Payment To CommonSense Ltd. Paving The Way For The Anticipated Closing Of Exclusive Sub-Distribution Agreement For Product AL-Sense with 2nd Quarter Launch
March 22, 2017
Easton Pharmaceuticals Provides Update On Its Previous Investment Into AMFIL Technologies and Their Recent Revenue Producing Acquisitions & The GROzone Technology For The Medical Marijuana Industry; Initiates Negotiations For Proposed Investment
March 15, 2017
Easton Pharmaceuticals Provides Update On Acquiring Major Vaporizer and e-Liquids Manufacturer iBliss, Inc.
March 8, 2017
Easton Pharmaceuticals Announces The Closing Of A Financing Facility With Additional Financing Commitments; Provides Other Updates
March 3, 2017
Easton Pharmaceuticals / BMV Medica Announces Successful Product Sales Launch Conference Of Product Gynofit and Additional Distribution of Product AL-Sense (AmnioSense) With Multi-National Pharmaceutical Company Gedeon Richter
February 21, 2017
Easton Pharmaceuticals Provides Update On its Licensed Women's Diagnostics Products (VS-Sense, AL-Sense) and Other Updates
February 8, 2017
Easton Pharmaceuticals and BMV Medica Announces First Shipment of Gynofit To Multi-National Pharmaceutical Company, Gedeon Richter, Towards Its Purchase Order, Has Been Received For February 16th Product Launch in Puerto Vallarta, Mexico
February 3, 2017
Easton Pharmaceuticals Signs Letter Of Intent to Acquire Major Vaporizer and e-Liquids Manufacturer iBliss Inc.
January 23, 2017
Easton Pharmaceuticals and Partner BMV Medica Announce Receipt of First Purchase Order For Mexico's Launch for Gynofit -- Lactic Acid Gel Treatment From Gedeon Richter
January 4, 2017
Easton Pharmaceuticals and Partner BMV Medica Sign First Sales & Marketing Agreement with European Based, Multi-National Pharmaceutical Company, Gedeon Richter, For Women's Health, Sales & Marketing of its Gynofit -- Lactic Acid Gel Treatment of B
December 14, 2016
Easton Pharmaceuticals Announces Negotiations For The Filing Of A Medical Marijuana Application In Jamaica Toward Exporting Medicinal Marijuana Into various Countries Including Canada, Mexico, and Brazil
November 28, 2016
Easton Pharmaceuticals Announces It Has Moved Toward Signing Sales & Distribution Agreement With Women's Health-Focused Multi-National European Pharma Company for Its VS-Sense, AL-Sense and Gynofit Products
May 10, 2016
Easton Pharmaceuticals and Partner BMV Medica Announces Sales & Distribution Negotiations With Womens Health-Focused Multi-National European Pharma Company
April 6, 2016
Easton Pharmaceuticals and Partner BMV Medica Announces Regulatory Filing of Its Patented Women's Health Diagnostic Product, VS-Sense for the Mexico Market, Provides Update on Generic Cancer Drugs, Paclitaxel, Docetaxel
February 16, 2016
Easton Pharmaceuticals Letter to Shareholders and Update
October 7, 2015
Easton Pharmaceuticals Announces Finalized Agreement to Secure All of Spanish-Speaking Latin America, Adding to Its Mexico Rights for the VS-Senses Patented Women's Vaginal Health Diagnostic Test
September 15, 2015
Easton Pharmaceuticals Closes on First Wholesale Sales Order for Skin Renou HA for Mexico and Other Latin American Countries With BMV Medica
August 26, 2015
Easton Pharmaceuticals Announces Major Initiative Supporting Its Focus on Unique Patented Women's Health Products With the Appointment of Dr. Jose Tiran as Founding Member of Easton's Medical/Scientific Advisory Board in Women's Health
August 17, 2015
Easton Pharmaceuticals and BMV Medica Finalize License Agreement With CommonSense Ltd. of Israel to Be Sole Distributor for Patented AL-Sense (Amnio-Sense-Blue) Amniotic Fluid Leak Test for Latin America
August 4, 2015
Easton Pharmaceuticals Announces the Appointment of Evan Karras as CEO / Director and Mr. Nunzio Valerie as President / CFO; Mr. Karras Possesses a Strong Background in Canadian and International Commercial Successes and Is Expected to Make Major Impact o
July 29, 2015
Easton Pharmaceuticals / BMV Medica Announces Its Mexican Ministry of Health and Latin America Regulatory Filing and Approval Process for Cancer Drugs Paclitaxel and Docetaxel From Biolyse Pharma Has Been Shortened
July 6, 2015
Easton Pharmaceuticals and BMV Medica Announce Eva Pro as Brand Name for Its Line of Patented Women's Diagnostic Tests for the Mexican and Other Latin American Markets; Trademark Registration of Individual Product Names, Logos and Packaging Has Commenced
June 23, 2015
Easton Pharmaceuticals and BMV Medica Sign MOU Towards Exclusive Distribution for Woman's Patented Diagnostic Test for Amniotic Fluid Detection for Women in Late Pregnancy for the Majority of Latin American Countries
June 18, 2015
Easton Pharmaceuticals Moves to Directly Negotiate Exclusive Agreement With Private Medical Marijuana Grower in Canada as a Result of Galileo Life Science's Actions Toward Its Previously Executed Option and Purchase Agreement; Provides Formal Action Respo
June 17, 2015
Easton Pharmaceuticals and BMV Medica Close on Joint Distribution Agreement for Injectable Approved Cancer Drugs for Mexico and Other Latin American Countries With Biolyse Pharma Corporation
June 15, 2015
Easton Pharmaceuticals Signs MOU Towards Distributing a Line of Injectable Approved Cancer Drugs for Mexico and Other Latin American Countries; Further Announces It Is Not Canceling Its Canadian Medical Marijuana Option With MDRM, Stays Committed To Medic
June 8, 2015
Easton Pharmaceuticals Announces It Has Provided Notification and Entered Into Discussions to Terminate Its Canadian Medical Marijuana Option Agreement With MDRM Canada
June 1, 2015
Easton Pharmaceuticals Announces Successful Launch of Its First 3 OTC Products at Recently Attended Trade Shows, the Total Health Show and Yoga Shows; Proceeds Towards Completion of Its 2014 Year End Audit
April 28, 2015
Easton Pharmaceuticals Announces Finalized Joint Partnership Agreement With BMV Medica for Exclusive Rights to Distribute World Patented Women's Health Diagnostic Test in Mexico From Israel-Based Common Sense Ltd.
April 22, 2015
Easton Pharmaceuticals Announces a Signed Agreement With Colorado Product Services, LLC and Cultiv8, LLC Towards the Purchase of a Recreational Marijuana Dispensary, Cultivation Facility and Lab in Carbondale, Colorado
April 20, 2015
Easton Pharmaceuticals Announces North American Products Distribution and Intellectual Property Agreement With NutraShop Global Stores, a Large Online Quality Wellness and Therapeutic Products Retailer; Provides Other Updates
March 19, 2015
Easton Pharmaceuticals Announces Memorandum of Understanding With Broken Coast Cannabis Ltd, a Health Canada Licensed MMPR Provider
March 16, 2015
Easton Pharmaceuticals Inc. Provides Update on the AMFIL GroZone Technology for the Medical Marijuana Industry and Moves Towards Implementation Within Medicated Markets California Operations
March 2, 2015
Easton Pharmaceuticals Discloses Existing Medicated Market Revenues From Its Medical Marijuana Operations That Have Surpassed $2,000,000; Provides Clarification on Other Items
February 24, 2015
Easton Pharmaceuticals Unveils Medicated Markets Revenue Projections for Fiscal 2015
February 17, 2015
Easton Pharmaceuticals Provides Update on Its Medicated Markets Partnership, Joint Initiatives and the Booming Medical Marijuana Climate in California for January 2015
February 9, 2015
Easton Pharmaceuticals Releases December Vaporizer Sales, Highlighting a 62% Month Over Month Increase in Revenues on Fiscal 2014 Vaporizer Segment Revenues
February 5, 2015
Easton Pharmaceuticals Discloses List of Joint Initiatives With Medicated Markets International LLC, Its California Based Medical Marijuana Partner
January 28, 2015
Easton Pharmaceuticals Inc Is Pleased to Announce Definitive Finalized Agreement With Medicated Markets International LLC, a Major California Based Medical Marijuana Grower
January 20, 2015
Easton Pharmaceuticals Provides Medicated Markets Due Diligence Update With the Disclosure of Total Number of Plants, Strains and Dispensaries Currently Being Serviced
January 12, 2015
Easton Pharmaceuticals Announces Signed Agreement With Medicated Markets International LLC, A Major California-Based Medical Marijuana Grower
December 31, 2014
Easton Pharmaceuticals Inc. Suspends All Potentially Dilutive Financing as a Direct Result of Negotiations With a Major California Based Medical Marijuana Grow-Op
December 22, 2014
Easton Pharmaceuticals Releases Preliminary Vaporizer Related Sales of $25,638.00 in the Month of November
December 15, 2014
Easton Pharmaceuticals Executes Letter of Intent and Provides Details on Green Patient Network's Business Plan
December 12, 2014
Easton Pharmaceuticals Initiates Discussions With Canadian Medical Marijuana Association / Club
December 10, 2014
Easton Pharmaceuticals Announces Positive Updates, Changes to Its OTC Therapeutic Products, Manufacturing and North American Distributorship
December 8, 2014